Hao Zhang

Hao Zhang

Auto-generated profile, based on publicly available information

Hao Zhang

Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
LRLU Ren
LU Ren
RGRaghavender R. Gopireddy
Raghavender R. Gopireddy
GPGuy Perkins
Guy Perkins
HZHao Zhang
Hao Zhang
VTValeriy Timofeyev
Valeriy Timofeyev
NCNipavan Chiamvimonvat
Nipavan Chiamvimonvat
The sinoatrial node (SAN), the leading pacemaker region, generates electrical impulses that propagate throughout the heart. SAN dysfunction with bradyarrhythmia is well documented in heart failure (HF). However, the underlying mechanisms are not completely understood. Mitochondria are critical to cellular processes that determine the life or death of the cell. The release of Ca 2+ from the ryanodine receptors 2 (RyR2) on the sarcoplasmic reticulum (SR) at mitochondria–SR microdomains serves as the critical communication to match energy production to meet metabolic demands. Therefore, we tested the hypothesis that alterations in the mitochondria–SR connectomics contribute to SAN dysfunction in HF. We took advantage of a mouse model of chronic pressure overload–induced HF by transverse aortic constriction (TAC) and a SAN-specific CRISPR-Cas9–mediated knockdown of mitofusin-2 ( Mfn2 ), the mitochondria–SR tethering GTPase protein. TAC mice exhibited impaired cardiac function with HF, cardiac fibrosis, and profound SAN dysfunction. Ultrastructural imaging using electron microscope (EM) tomography revealed abnormal mitochondrial structure with increased mitochondria–SR distance. The expression of Mfn2 was significantly down-regulated and showed reduced colocalization with RyR2 in HF SAN cells. Indeed, SAN-specific Mfn2 knockdown led to alterations in the mitochondria–SR microdomains and SAN dysfunction. Finally, disruptions in the mitochondria–SR microdomains resulted in abnormal mitochondrial Ca 2+ handling, alterations in localized protein kinase A (PKA) activity, and impaired mitochondrial function in HF SAN cells. The current study provides insights into the role of mitochondria–SR microdomains in SAN automaticity and possible therapeutic targets for SAN dysfunction in HF patients.


1 January 1995 in Biochemical Pharmacology
Verified
Journal Article
Closed access
HFHarry Ford
Harry Ford
JDJohn S. Driscoll
John S. Driscoll
ZHZhang Hao
Zhang Hao
KDKatherine A. Dobyns
Katherine A. Dobyns
MRMichael E. Rommel
Michael E. Rommel
DCDavid A. Cooney
David A. Cooney

24 September 2026 in Science
Verified
Journal Article
Closed access
HZHao Zhang
Hao Zhang
RSRabindra V. Shivnaraine
Rabindra V. Shivnaraine
LRLU Ren
LU Ren
PTPhung Thai
Phung Thai
RJRemi Janicot
Remi Janicot
JWJoseph C. Wu
Joseph C. Wu
Cardiac fibrosis independently predicts adverse outcomes in heart failure (HF), yet no Food and Drug Administration–approved therapy directly targets fibrotic remodeling in the heart. To address this unmet clinical need, we used a multidimensional drug discovery pipeline centered on a human induced pluripotent stem cell (iPSC)–based platform. Through high-throughput screening, we identified CGS15943 (CGS) as the lead antifibrotic compound and validated its activity in human cardiac fibroblasts, three-dimensional engineered heart tissues, and animal models of HF. Mechanistic studies revealed an atypical adenosine receptor (AR)–dependent signaling pathway in which AR subtypes converge on Gβγ (the βγ subunits of heterotrimeric GTP-binding proteins) to activate phosphoinositide 3-kinase (PI3K)–AKT and yes-associated protein (YAP). CGS suppressed this signaling axis, thereby reducing fibrotic gene expression and fibroblast activation. These findings establish AR-driven Gβγ signaling as a potential therapeutic target for cardiac fibrosis.

9 October 2026 in Circulation Research
Verified
Journal Article
Open access
HZHao Zhang
Hao Zhang
RHRihua Huang
Rihua Huang
PTPhung Thai
Phung Thai
LRLU Ren
LU Ren
RSRabindra V. Shivnaraine
Rabindra V. Shivnaraine
JWJoseph C. Wu
Joseph C. Wu

23 June 2026 in Circulation
Verified
Journal Article
Closed access
LRLU Ren
LU Ren
NBNadjet Belbachir
Nadjet Belbachir
HZHao Zhang
Hao Zhang
PTPhung Thai
Phung Thai
RHRihua Huang
Rihua Huang
JWJoseph C. Wu
Joseph C. Wu